Division of Maternal-Fetal Medicine and Perinatal Research, Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, Galveston, TX, USA; Biological Models Laboratory, Department of Biochemistry and Molecular Biology, College of Medicine, University of the Philippines Manila, Manila, Philippines.
Division of Maternal-Fetal Medicine and Perinatal Research, Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, Galveston, TX, USA; Department of Electrical and Computer Engineering, Department of Biomedical Engineering, Texas A&M University, College Station, TX, USA.
Mol Cell Endocrinol. 2021 Jun 1;529:111276. doi: 10.1016/j.mce.2021.111276. Epub 2021 Apr 3.
The cervix undergoes extensive remodeling throughout pregnancy and parturition. This process involves both ECM collagen degradation and cellular remodeling, which includes cell proliferation, transition and migration. Progesterone (P4) has been used clinically to delay cervical ripening and prevent preterm birth (PTB). However, the mechanisms by which progesterone affects cell transition and the migration of cervical epithelial and stromal cells are not yet fully known. In this study, we documented the role of a gestational level of P4 in the cellular transition (epithelial-mesenchymal transition [EMT] and mesenchymal-epithelial transition [MET]), cell migration, and inflammatory responses of endocervical epithelial cells (EEC) and cervical stromal cells (CSC). EEC and CSC were treated with LPS and P4 for 6 days. The epithelial:mesenchymal ratio (regular microscopy and cell shape index analysis), shift in intermediate filaments (immunofluorescence microscopy and western blot analyses for cytokeratin [CK]-18 and vimentin), adhesion molecules and transcription factors (western blot analyses for E-cadherin, N-cadherin and SNAIL), were used to determine growth characteristics and EMT and MET changes in EEC and CSC under the indicated conditions. To test cell remodeling, scratch assays followed by cellular analyses as mentioned above were performed. Inflammatory cytokines (interleukin-6 [IL-6], tumor necrosis factor α [TNFα]) and matrix metallopeptidase 9 (MMP9) were measured by ELISA. LPS promoted EMT (decreased cell shape index, decreased CK-18 and E-cadherin, increased vimentin, N-cadherin, and SNAIL), and increased IL-6 and MMP9 production by EEC. A gestational level of P4 prevented LPS-induced EMT in EEC and exhibited anti-inflammatory effect in both EEC and CSC. LPS slowed down wound healing in CSC but P4 treatment prevented the negative impact of LPS in CSC wound healing. These results may explain the cellular mechanisms by which P4 helps to stabilize the cervical epithelial barrier and preserve the mechanical and tensile strength of the cervical stromal layer, which are important in normal cervical remodeling processes during pregnancy.
子宫颈在妊娠和分娩过程中经历广泛的重塑。这个过程既涉及细胞外基质胶原的降解,也涉及细胞重塑,包括细胞增殖、过渡和迁移。孕酮(P4)已被临床用于延迟宫颈成熟并预防早产(PTB)。然而,孕酮影响宫颈上皮和基质细胞过渡和迁移的机制尚不完全清楚。在这项研究中,我们记录了妊娠水平的 P4 在细胞过渡(上皮-间充质过渡[EMT]和间充质-上皮过渡[MET])、细胞迁移以及宫颈上皮细胞(EEC)和宫颈基质细胞(CSC)的炎症反应中的作用。用 LPS 和 P4 处理 EEC 和 CSC 6 天。通过常规显微镜和细胞形状指数分析评估上皮-间充质比、中间丝的转移(角蛋白[CK]-18 和波形蛋白的免疫荧光显微镜和 western blot 分析)、粘附分子和转录因子(E-钙粘蛋白、N-钙粘蛋白和 SNAIL 的 western blot 分析),以确定在指示条件下 EEC 和 CSC 的生长特征和 EMT 和 MET 变化。为了测试细胞重塑,进行划痕实验,然后进行上述细胞分析。通过 ELISA 测量炎性细胞因子(白细胞介素 6 [IL-6]、肿瘤坏死因子α [TNFα])和基质金属蛋白酶 9(MMP9)。LPS 促进 EMT(细胞形状指数降低,CK-18 和 E-钙粘蛋白减少,波形蛋白、N-钙粘蛋白和 SNAIL 增加),并增加 EEC 中 IL-6 和 MMP9 的产生。妊娠水平的 P4 可防止 LPS 诱导的 EEC 中的 EMT,并对 EEC 和 CSC 均具有抗炎作用。LPS 减缓了 CSC 中的伤口愈合,但 P4 处理可防止 LPS 在 CSC 伤口愈合中的负面影响。这些结果可能解释了 P4 有助于稳定宫颈上皮屏障并维持宫颈基质层的机械和拉伸强度的细胞机制,这在妊娠期间正常的宫颈重塑过程中很重要。